Categories
Health

New York Metropolis’s Vaccine Passport Plan Renews On-line Privateness Debate

When New York City announced on Tuesday that people will soon have to show evidence of at least one coronavirus vaccine to get into businesses, Mayor Bill de Blasio said the system was “simple – just show it and you’re in”.

The data protection debate, which rekindled the city, was less straightforward.

Vaccination records showing proof of vaccination, often in electronic form such as an app, are the foundation of Mr de Blasio’s plan. For months, these records – also known as health cards or digital health certificates – have been discussed around the world in order to provide a safe gathering for vaccinated people who are less at risk from the virus. New York will be the first U.S. city to include these passports in a vaccine mandate, and potentially trigger similar actions elsewhere.

But mainstreaming those credentials could also usher in an era of increasing digital surveillance, privacy researchers said. This is because vaccine passports can allow location tracking, although there are few rules about how people’s digital vaccine data can be stored and shared. While existing data protection laws restrict the exchange of information between medical providers, there is no such rule for uploading your own data to an app.

The moment is reminiscent of the months after the September 11, 2001 attacks, said privacy advocates. Back then, changes in the name of national security had lasting effects, including taking off shoes at airports and the data collection made possible by the Patriot Act.

Without security, presenting a digital vaccination record every time people enter a public place could result in a “global map of the people,” said Allie Bohm, a political advisor to the New York Civil Liberties Union. The information could be used for profit by third parties or disclosed to law enforcement or immigration authorities, she said.

“How do we make sure that in 20 years we won’t say, ‘Well, there was Covid, so now I have this passport on my cell phone, which is also my driver’s license and also all the health records I have ever had? and every time I go to a store, do I have to leaf through it? ‘”said Ms. Boehm.

She added that the passports could particularly disadvantage groups who are more concerned about privacy, including those without papers. The New York Civil Liberties Union and other advocacy groups have supported laws to prevent vaccination records from being shared with law enforcement and to ensure passports don’t become permanent health trackers.

Vaccination records were introduced in the United States largely without a national framework. President Biden has ruled out a national vaccination record so that states, cities and private companies can decide if and how to have their own electronic systems to keep track of people who have been vaccinated.

Some companies that have developed digital vaccination records have tried to forestall privacy concerns. Over 200 private and public organizations recently joined the Immunization Card Initiative, a coalition aimed at standardizing the collection and protection of vaccination data.

Many developers said they went out of their way to make sure the passports didn’t break the privacy boundaries. Clear Secure, a security company that has created a health passport that is used by over 60 organizations, including many sports venues, said that its users’ health information has been “treated with the utmost care” and protected by a variety of tools. Employers or venues can only see a red or green signal that indicates whether a user has been vaccinated, it said.

The Commons Project, a non-profit organization that developed a vaccine passport called CommonPass, stores vaccine and test data on users’ phones and only temporarily uploads the information to a server to verify that a traveler meets the requirements. Airlines that have introduced CommonPass, including JetBlue and Lufthansa, can only see if a passenger has been cleared for travel, it said.

JP Pollak, a co-founder of the Commons Project, said the group’s vaccination record is “trustworthy” as users’ data has not been stored in the cloud and the passport restricts the information companies can see.

But while vaccine passports are still in the making, Covid-19 contact tracing apps that were introduced earlier in the pandemic have already been used by more authoritarian countries in a way that raises privacy issues. That gives researchers little confidence about how those vaccine passports might be used later.

For example, in China, a program called “reportInfoAndLocationToPolice” within the Alipay Health Code, used by the Chinese government to assess people’s health, sends a person’s location, city name, and identification code number to a server once the user agrees software access to personal data.

In Singapore, officials said in January that data from the country’s coronavirus contact tracing system had been used in a criminal investigation, despite leaders originally saying it was only used for contact tracing. In February, Singapore passed law restricting such use to “serious” criminal investigations.

“One of the things we don’t want is that we normalize surveillance in an emergency and we can’t get rid of it,” said Jon Callas, the director of technology projects at the Electronic Frontier Foundation, a digital rights group.

Although such incidents do not occur in the United States, researchers already see potential for a handover. Several pointed to New York City, where proof of compulsory vaccination begins August 16 and will be enforced from September 13.

For evidence, people can use their paper vaccination cards, the NYC Covid Safe app, or another app called the Excelsior Pass. The Excelsior Pass was developed by IBM under an estimated $ 17 million contract with New York State.

To receive the pass, people upload their personal information. In the standard version of the pass, companies and third parties only see the validity of the pass and the name and date of birth of the person.

On Wednesday, the state announced the “Excelsior Pass Plus”, which not only shows whether a person has been vaccinated, but also provides additional information on when and where they were vaccinated. Companies that scan Pass Plus “may have the ability to save or retain the information it contains,” according to New York State.

The Excelsior Pass also has a “Phase 2” which could include expanding the use of the app and adding more information such as personal information and other health records that companies could review upon entry.

IBM said it used blockchain technology and encryption to protect user data, but didn’t say how. The company and New York State did not respond to requests for comment.

Mr de Blasio told WNYC in April that he understands the privacy concerns surrounding the Excelsior Pass but believes it will still “play an important role”.

Some federal states and cities are proceeding cautiously for the time being. More than a dozen states, including Arizona, Florida, and Texas, have announced bans on vaccination records in the past few months. The mayors of San Francisco, Los Angeles, and Seattle also said they would hold back on passport programs.

Some groups of companies and companies that have introduced vaccine passports said the privacy concerns were legitimate but addressable.

Airlines for America, an industrial trade group, said it supported vaccine passports and urged the federal government to put in place privacy standards. The San Francisco Chamber of Commerce, which helps its members work with Clear, said it was preferable to use the tools to ensure that only vaccinated people enter stores than to have companies close again when virus cases rise.

“People’s privacy is precious,” said Rodney Fong, President of the Chamber, but “when it comes to saving lives, privacy becomes a little less important.”

Categories
Health

Covid Lab-Leak Idea Renews ‘Achieve-of-Perform’ Analysis Debate

In the United States, “there are no biosafety rules or regulations that have the force of law,” he said. “And this is in contrast to every other aspect of biomedical research.” There are enforceable rules, for example, for experiments with human subjects, vertebrate animals, radioactive materials and lasers, but none for research with disease-causing organisms.

Dr. Relman, who also supports the need for independent regulation, cautioned that legal restrictions, as opposed to guidelines or more flexible regulations, could also pose problems. “The law is cumbersome and slow,” he said. At one point in the evolution of laws relating to biological warfare, for example, Congress prohibited the possession of smallpox. But the rule’s language, Dr. Relman said, also seemed to ban possession of the vaccine because of its genetic similarity to the virus itself. “To try to fix it took forever,” he said.

The current H.H.S. policy also doesn’t offer much guidance about working with scientists in other countries. Some have different policies about gain-of-function research, while others have none at all.

Dr. Gronvall of Johns Hopkins argued that the U.S. government cannot dictate what scientists do in other parts of the world. “You have to embrace self-governance,” she said. “You’re not able to sit on everyone’s shoulder.”

Even if other countries fall short on gain-of-function research policies, Dr. Lipsitch said that shouldn’t stop the United States from developing better ones. As the world’s leader in biomedical research, the country could set an example. “The United States is sufficiently central,” Dr. Lipsitch said. “What we do really does matter.”

Ironically, the pandemic put deliberations over such issues on hold. But there’s no question the coronavirus will influence the shape of the debate. Jesse Bloom, a virologist at the Fred Hutchinson Cancer Research Center, said that before the pandemic, the idea of a new virus sweeping the world and causing millions of deaths felt hypothetically plausible. Now he has seen what such a virus can do.

“You have to think really carefully about any kind of research that could lead to that sort of mishap in the future,” Dr. Bloom said.

Categories
Health

Covid Lab-Leak Principle Renews “Achieve-of-Operate” Analysis Debate

In the United States, “there are no biosafety rules or regulations that have the force of law,” he said. “And this is in contrast to every other aspect of biomedical research.” There are enforceable rules, for example, for experiments with human subjects, vertebrate animals, radioactive materials and lasers, but none for research with disease-causing organisms.

Dr. Relman, who also supports the need for independent regulation, cautioned that legal restrictions, as opposed to guidelines or more flexible regulations, could also pose problems. “The law is cumbersome and slow,” he said. At one point in the evolution of laws relating to biological warfare, for example, Congress prohibited the possession of smallpox. But the rule’s language, Dr. Relman said, also seemed to ban possession of the vaccine because of its genetic similarity to the virus itself. “To try to fix it took forever,” he said.

The current H.H.S. policy also doesn’t offer much guidance about working with scientists in other countries. Some have different policies about gain-of-function research, while others have none at all.

Dr. Gronvall of Johns Hopkins argued that the U.S. government cannot dictate what scientists do in other parts of the world. “You have to embrace self-governance,” she said. “You’re not able to sit on everyone’s shoulder.”

Even if other countries fall short on gain-of-function research policies, Dr. Lipsitch said that shouldn’t stop the United States from developing better ones. As the world’s leader in biomedical research, the country could set an example. “The United States is sufficiently central,” Dr. Lipsitch said. “What we do really does matter.”

Ironically, the pandemic put deliberations over such issues on hold. But there’s no question the coronavirus will influence the shape of the debate. Jesse Bloom, a virologist at the Fred Hutchinson Cancer Research Center, said that before the pandemic, the idea of a new virus sweeping the world and causing millions of deaths felt hypothetically plausible. Now he has seen what such a virus can do.

“You have to think really carefully about any kind of research that could lead to that sort of mishap in the future,” Dr. Bloom said.

Categories
Business

AMC upgraded as ‘Godzilla vs. Kong’ renews confidence in field workplace

AMC Empire 25 in Times Square is open as New York City theaters reopen for the first time in a year after the coronavirus shutdown on March 5, 2021.

Angela Weiss | AFP | Getty Images

“Godzilla vs. Kong” restores confidence in the future of the box office.

The Warner Bros. ‘film, which released the best opening weekend of any movie released during the coronavirus pandemic, “destroys ongoing concerns about the importance of the cinema window and shows a solid path to resurgence,” wrote Eric Wold, an analyst at B. Riley Securities, in a report on Monday.

“Godzilla vs. Kong” signals that consumers are dying to hit theaters for new blockbuster features and suggests that the upcoming summer slate could have similar success.

Wold also switched AMC Entertainment to “Buy” on its Monday listing and raised its price target from $ 7 to $ 13. The company’s shares rose more than 15% on Monday and have risen more than 410% since January, partly due to renewed confidence in the company’s ability to weather the remainder of the pandemic. AMC has a market value of $ 4.2 billion.

“We remain impressed with the management’s ability to weather the pandemic headwinds by both strengthening the bottom line and negotiating with landlords to improve the runway by 2022,” he wrote. “And as the largest exhibitor in North America that also operates most of the premium IMAX screens, we see AMC as well-positioned to benefit from the forecast industry recovery and to match pre-pandemic visitor numbers by 2023.”

AMC has been hit by the pandemic. The company was already in debt to acquiring smaller theater chains and adding luxury seating to its existing locations. Closures, capacity constraints, and the lack of new movie releases put a significant strain on the company’s finances.

The performance of “Godzilla vs. Kong” is a bright light for AMC and the rest of the cinema industry.

The film, which debuted domestically on Wednesday and released on HBO Max, grossed $ 32.2 million on Friday, Saturday and Sunday and brought in $ 48.5 million for the entire five-day Easter weekend in the US and Canada a.

“We believe consumers want to leave the house and return to the theater, and these results are very telling, especially considering the film was available for free to HBO Max subscribers at the same time it opened in theaters,” Wold wrote.

Notably, less than 60% of the North American theater base was open on weekends, and theater capacity constraints remain between 25% and 50%.

“We think these results are impressive considering the previous movie, Godzilla: King of the Monsters, opened for just $ 47.8 million in May 2019 (all theaters are open with no capacity restrictions) “wrote Wold.

Categories
Politics

Richard Burr’s Vote to Convict Renews Speak of a Lara Trump Run in North Carolina

Senator Richard M. Burr’s decision to vote for the condemnation of former President Donald J. Trump on Saturday fueled speculation that Lara Trump, the daughter-in-law of Mr. Trump, will seek the seat of the North Carolina Senate Mr Burr will vacate in 2022.

South Carolina Senator Lindsey Graham, a former Trump critic turned strong defender, predicted Sunday that Mr. Burr’s somewhat surprising dissent would spark a right-wing riot that would lead to the election of more pro-Trump candidates.

“My friend Richard Burr made Lara Trump almost a sure-fire candidate for the Senate seat in North Carolina to replace if she runs,” he said in an interview with Fox News.

Ms. Trump, 38, a former personal trainer and television producer who grew up on the coast in Wilmington, has been hovering as a potential Burr successor for months.

She did not immediately respond to a request for comment. A senior Republican official, aware of her plans, said the January 6 riot pissed her off at running, but Ms. Trump would decide over the next few months whether to run as part of a coordinated Trump family comeback.

Another Republican, former Representative Mark Walker, an ally of Trump, has already announced his candidacy, and Pat McCrory, a former Republican governor, is also a possible candidate. Mark Meadows, the former North Carolina representative and former Trump chief of staff, is also said to be there.

“We’re going to take a closer look at each candidate in comparison to some sort of coronation,” said Mark Brody, a member of the Republican National Committee from Union County outside Charlotte.

Doug Heye, a former RNC spokesman who previously worked for Mr. Burr, asked if Ms. Trump was ready to endure the hassle and boredom of running or serving. “A lot of people love speculation and attention, but being a senator is a lot of hard work,” he said.

Then there is the question of residence. Ms. Trump currently lives in the northern suburbs of New York City with her husband Eric and their children and would have to move back.

If she runs, the Trump family could be a liability on a battlefield that the former president only gained 1.3 percentage points in 2020 – or it could bring no benefit at all in 2022, depending on the political environment.

“There’s a myth that Trump voters will come out for Trump candidates or family members,” said John Anzalone, a Democratic pollster who has campaigned in the South. “Cult members only appear in full power for the cult leader.”

And Ms. Trump’s candidacy could help increase Democratic turnout, especially among the state’s large black population, and counter the typical decline in most mid-term elections.

But Ms. Trump’s boosters, led by Mr. Graham, hope that she can use the backlash in the party’s grassroots base to catapult her to the top of the field.

After Mr Burr’s vote, the North Carolina Republican Party reprimanded Mr Burr, calling his vote “shocking and disappointing”.

Representative Patrick T. McHenry, a Republican minority leader in the House, downplayed the importance of Mr Burr’s vote.

But he said Ms. Trump would be “the favorite” when she runs, adding, “Nobody comes closer.”